# Aesthetics announced
Allergan Aesthetics, the AbbVie aesthetics business, has launched AA Signature in the US: a structured consultation framework to guide health care providers through multimodal facial assessments and individualized treatment planning. The rollout begins with AA Signature: SKIN360, described as the first of several planned protocols.
# What SKIN360 covers
SKIN360 targets patients who want smoother, more hydrated skin across multiple facial and related anatomical regions. The protocol directs providers to assess three modalities together as part of a consultation pathway:
- Skinvive by Juvederm: an intradermal microdroplet injection indicated to improve cheek smoothness and hydration.
- SkinMedica HA5 Hydra Collagen Hydrator with Vegan Collagen: a topical hydrator aimed at supporting long-term skin health and visible plumping.
- Botox Cosmetic (onabotulinumtoxinA): an FDA-approved injectable for temporarily improving certain facial lines and platysma bands.
Allergan Aesthetics notes that the safety and efficacy of combining these three products have not been evaluated.
# Why Allergan is promoting a protocol approach
- Practices that adopt multimodal treatment planning reportedly achieve 68% higher patient retention compared with practices treating a single concern.
- A cited survey shows 96% of patients expressed interest in receiving a "comprehensive" consultation.
- A separate category-wide study found that eight out of 10 patients chose to proceed with treatment after a comprehensive assessment that recommended two or more in-office procedures or products.
These findings are used by Allergan Aesthetics to argue that structured, multimodal consultations can increase patient engagement and conversion to multi-product regimens.
# Clinical and practice implications
The company plans to expand AA Signature with protocols that will address tissue lift, structural volume, skin firmness, and facial definition through 2027. Practices should note the explicit company statement that combined use of the three SKIN360 products has not been studied for safety or efficacy.
# What this means for practices and patients
For practices: AA Signature provides a repeatable consultation framework and educational resources tied to specific product options. The program is intended to systematize how providers evaluate multiple facial concerns in a single consultation.
For patients: Allergan frames the approach as a pathway to more comprehensive, multimodal treatment plans. The company's cited data indicate strong patient interest in comprehensive assessments and a higher likelihood of proceeding with multi-procedure plans after such consultations.
# Next steps announced by Allergan
Allergan Aesthetics will continue to release additional AA Signature protocols through 2027, expanding beyond skin quality into areas such as lift and volume. Clinics interested in adopting the framework will likely receive protocol materials and access to Allergan Medical Institute resources as part of the rollout.